• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可变剪接的组织因子途径抑制剂:功能意义

Alternatively spliced tissue factor pathway inhibitor: functional implications.

作者信息

Mast Alan E

机构信息

Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI 53201-2178, USA.

出版信息

Front Biosci (Schol Ed). 2011 Jun 1;3(4):1457-62. doi: 10.2741/236.

DOI:10.2741/236
PMID:21622281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3549618/
Abstract

Tissue factor pathway inhibitor (TFPI) is a factor Xa dependent inhibitor of tissue factor initiated blood coagulation. In recent years several alternatively spliced forms of TFPI have been identified. These alternatively spliced forms have different C-terminal regions and have different mechanisms for association with cell surfaces. They are differentially expressed in human and mouse tissues and may have distinct physiological functions.

摘要

组织因子途径抑制物(TFPI)是一种依赖于因子Xa的组织因子启动的血液凝固抑制物。近年来,已鉴定出TFPI的几种可变剪接形式。这些可变剪接形式具有不同的C末端区域,并且与细胞表面结合的机制也不同。它们在人和小鼠组织中差异表达,可能具有不同的生理功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/c5113eb53e6c/nihms433494f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/4f71dc3f4124/nihms433494f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/9d4dd529068d/nihms433494f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/7fbd3f21da28/nihms433494f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/c5113eb53e6c/nihms433494f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/4f71dc3f4124/nihms433494f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/9d4dd529068d/nihms433494f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/7fbd3f21da28/nihms433494f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bff5/3549618/c5113eb53e6c/nihms433494f4.jpg

相似文献

1
Alternatively spliced tissue factor pathway inhibitor: functional implications.可变剪接的组织因子途径抑制剂:功能意义
Front Biosci (Schol Ed). 2011 Jun 1;3(4):1457-62. doi: 10.2741/236.
2
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.组织因子途径抑制剂-γ是组织因子途径抑制剂的一种活性可变剪接形式,存在于小鼠而非人类中。
J Thromb Haemost. 2008 Aug;6(8):1344-51. doi: 10.1111/j.1538-7836.2008.03033.x. Epub 2008 May 22.
3
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor Xa.组织因子途径抑制物:对因子Xa的最佳抑制作用需要羧基末端。
Blood. 1992 Apr 15;79(8):2004-10.
4
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.组织因子途径抑制剂可变剪接形式在小鼠中的时序表达
J Thromb Haemost. 2009 Jul;7(7):1106-13. doi: 10.1111/j.1538-7836.2009.03454.x. Epub 2009 Apr 24.
5
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.鼠造血细胞组织因子途径抑制剂可限制血栓生长。
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):821-6. doi: 10.1161/ATVBAHA.110.220293. Epub 2011 Jan 13.
6
Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.组织因子途径抑制物剪接变异体的细胞表达和生物学活性。
Curr Opin Hematol. 2013 Sep;20(5):403-9. doi: 10.1097/MOH.0b013e3283634412.
7
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.基质金属蛋白酶-8降解后组织因子途径抑制物的结构与功能特征
Biochem J. 2002 Oct 15;367(Pt 2):451-8. doi: 10.1042/BJ20020696.
8
Tissue factor pathway inhibitor binds to platelet thrombospondin-1.组织因子途径抑制剂与血小板凝血酶敏感蛋白-1结合。
J Biol Chem. 2000 Oct 13;275(41):31715-21. doi: 10.1074/jbc.M006595200.
9
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂:结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
10
The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.人组织因子途径抑制物的第二个Kunitz结构域:克隆、结构测定及与因子Xa的相互作用
J Mol Biol. 1997 Jun 13;269(3):395-407. doi: 10.1006/jmbi.1997.1029.

引用本文的文献

1
Regulation of factor V and factor V-short by TFPIα: Relationship between B-domain proteolysis and binding.TFPIα 对因子 V 和因子 V 短片段的调节:B 结构域蛋白水解与结合的关系。
J Biol Chem. 2021 Jan-Jun;296:100234. doi: 10.1074/jbc.RA120.016341. Epub 2021 Jan 7.
2
Regulation of vascular function on posttranscriptional level.转录后水平上血管功能的调节。
Thrombosis. 2013;2013:948765. doi: 10.1155/2013/948765. Epub 2013 Oct 31.
3
Restoring the procofactor state of factor Va-like variants by complementation with B-domain peptides.

本文引用的文献

1
C-terminal peptides of tissue factor pathway inhibitor are novel host defense molecules.组织因子途径抑制剂的 C 端肽是新型的宿主防御分子。
J Biol Chem. 2010 Sep 3;285(36):28387-98. doi: 10.1074/jbc.M110.127019. Epub 2010 Jun 30.
2
The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.TFPI-α 的 Kunitz-3 结构域是蛋白 S 依赖性增强因子 Xa 抑制所必需的。
Blood. 2010 Aug 26;116(8):1344-51. doi: 10.1182/blood-2009-10-246686. Epub 2010 May 17.
3
Alternatively spliced isoforms of tissue factor pathway inhibitor.
通过与 B 结构域肽互补恢复因子 Va 样变体的辅因子状态。
J Biol Chem. 2013 Oct 18;288(42):30151-30160. doi: 10.1074/jbc.M113.506840. Epub 2013 Sep 6.
组织因子途径抑制物的剪接异构体。
Thromb Res. 2010 Apr;125 Suppl 1:S52-6. doi: 10.1016/j.thromres.2010.01.038. Epub 2010 Feb 21.
4
Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C-terminal peptides eliminate serum-resistant Escherichia coli from blood cultures.片段化组织因子途径抑制剂(TFPI)和TFPI C末端肽可从血培养物中清除血清耐药性大肠杆菌。
J Infect Dis. 2009 Jun 15;199(12):1807-15. doi: 10.1086/599097.
5
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.组织因子途径抑制剂可变剪接形式在小鼠中的时序表达
J Thromb Haemost. 2009 Jul;7(7):1106-13. doi: 10.1111/j.1538-7836.2009.03454.x. Epub 2009 Apr 24.
6
Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.组织因子途径抑制剂-γ是组织因子途径抑制剂的一种活性可变剪接形式,存在于小鼠而非人类中。
J Thromb Haemost. 2008 Aug;6(8):1344-51. doi: 10.1111/j.1538-7836.2008.03033.x. Epub 2008 May 22.
7
Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor.蛋白S增强组织因子途径抑制物对因子Xa的抑制作用,但不增强其对因子VIIa-组织因子的抑制作用。
J Thromb Haemost. 2008 Jun;6(6):1044-6. doi: 10.1111/j.1538-7836.2008.02980.x. Epub 2008 Apr 14.
8
Active tissue factor pathway inhibitor is expressed on the surface of coated platelets.活性组织因子途径抑制物在包被血小板表面表达。
Blood. 2007 Mar 1;109(5):1931-7. doi: 10.1182/blood-2006-07-037283. Epub 2006 Nov 2.
9
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor.蛋白S通过组织因子途径抑制物刺激对组织因子途径的抑制作用。
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3106-11. doi: 10.1073/pnas.0504240103. Epub 2006 Feb 17.
10
Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.小窝蛋白-1增强组织因子途径抑制物在细胞表面的暴露及功能。
J Biol Chem. 2005 Jun 10;280(23):22308-17. doi: 10.1074/jbc.M503333200. Epub 2005 Apr 6.